Profile | GDS4284 / 212472_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 876.63 | 72 |
GSM687648 | Patient 402 control | 1092.45 | 75 |
GSM687653 | Patient 403 control | 280.459 | 56 |
GSM687658 | Patient 404 control | 729.47 | 69 |
GSM687663 | Patient 411 control | 991.71 | 74 |
GSM687668 | Patient 422 control | 762.524 | 70 |
GSM687673 | Patient 424 control | 2450.34 | 86 |
GSM687678 | Patient 425 control | 865.108 | 71 |
GSM687683 | Patient 427 control | 1154.32 | 76 |
GSM687688 | Patient 428 control | 485.99 | 63 |
GSM687695 | Patient 441 control | 7285.76 | 96 |
GSM687699 | Patient 443 control | 1448.15 | 80 |
GSM687704 | Patient 444 control | 630.515 | 67 |
GSM687707 | Patient 448 control | 606.264 | 66 |
GSM687712 | Patient 449 control | 750.713 | 70 |
GSM687719 | Patient 450 control | 1853.26 | 83 |
GSM687724 | Patient 451 control | 1336.75 | 79 |
GSM687728 | Patient 452 control | 1498.82 | 80 |
GSM687646 | Patient 401 treated 24h | 444.369 | 61 |
GSM687649 | Patient 402 treated 24h | 733.616 | 69 |
GSM687665 | Patient 411 treated 24h | 1282.25 | 78 |
GSM687651 | Patient 402 treated 4 weeks | 909.588 | 72 |
GSM687667 | Patient 411 treated 4 weeks | 617.276 | 66 |
GSM687670 | Patient 422 treated 24h | 996.512 | 73 |
GSM687671 | Patient 422 treated 4 weeks | 994.705 | 73 |
GSM687654 | Patient 403 treated 24h | 449.062 | 63 |
GSM687675 | Patient 424 treated 24h | 2735.06 | 88 |
GSM687685 | Patient 427 treated 24h | 1113.17 | 75 |
GSM687656 | Patient 403 treated 4 weeks | 522.031 | 65 |
GSM687677 | Patient 424 treated 4 weeks | 983.072 | 73 |
GSM687687 | Patient 427 treated 4 weeks | 460.628 | 62 |
GSM687692 | Patient 428 treated 4h | 741.706 | 69 |
GSM687716 | Patient 449 treated 4h | 412.514 | 61 |
GSM687722 | Patient 450 treated 4h | 1641.03 | 81 |
GSM687680 | Patient 425 treated 24h | 955.389 | 73 |
GSM687690 | Patient 428 treated 24h | 955.048 | 74 |
GSM687700 | Patient 443 treated 24h | 4720.85 | 93 |
GSM687705 | Patient 444 treated 24h | 684.146 | 69 |
GSM687714 | Patient 449 treated 24h | 700.515 | 69 |
GSM687721 | Patient 450 treated 24h | 4068.51 | 92 |
GSM687682 | Patient 425 treated 4 weeks | 595.312 | 67 |
GSM687694 | Patient 428 treated 4 weeks | 1059.49 | 74 |
GSM687702 | Patient 443 treated 4 weeks | 1237 | 77 |
GSM687718 | Patient 449 treated 4 weeks | 531.68 | 65 |
GSM687723 | Patient 450 treated 4 weeks | 1231.49 | 77 |
GSM687661 | Patient 404 treated 4h | 867.497 | 72 |
GSM687710 | Patient 448 treated 4h | 492.004 | 64 |
GSM687726 | Patient 451 treated 4h | 1333.6 | 78 |
GSM687730 | Patient 452 treated 4h | 1420.62 | 80 |
GSM687660 | Patient 404 treated 24h | 3179.38 | 90 |
GSM687697 | Patient 441 treated 24h | 3944.03 | 92 |
GSM687709 | Patient 448 treated 24h | 584.428 | 66 |
GSM687725 | Patient 451 treated 24h | 1679.37 | 82 |
GSM687729 | Patient 452 treated 24h | 4041.76 | 92 |
GSM687727 | Patient 451 treated 4 weeks | 896.378 | 72 |
GSM687731 | Patient 452 treated 4 weeks | 1537.16 | 80 |